Global expansion Avalere Health has expanded its presence internationally, including a new Japan office and strategic offerings for Asian markets, signaling growing opportunities to partner on regulatory, market access, and payer strategies in Asia.

Pharma market access PAI and Avalere specialize in health economics, outcomes research, value assessments, and payer-centric strategies, presenting a strong opportunity to support pharmaceutical and biotech clients with evidence generation, pricing, and access analytics.

Rich publication footprint With author credits in top journals and a long track record in health economics and outcomes research, there is potential to leverage intellectual capital for case studies, thought leadership, and commissioned research projects that showcase impact to prospective clients.

Integrated care pathways Recent launches around precision oncology, CGP patient access guides, and end-to-end lifecycle offerings indicate demand for integrated solutions across drug development, market access, and patient access programs.

Strategic leadership Senior talent moves and advisory capabilities (policy, health economics, and market access) create opportunities to engage large biopharma and diagnostics clients seeking experienced guidance on policy, reimbursement, and regulatory strategy.